[代谢综合征和精神分裂症的抗精神病治疗]
1Saint Petersburg State University, St. Petersburg, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|December 18, 2024
概括
代谢障碍与精神分裂症和抗精神病治疗有关. 本综述涵盖了代谢综合征风险,抗精神病药物的副作用以及精神分裂症患者的管理策略.
科学领域:
- 精神病学是一个精神病学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 精神分裂症的治疗通常涉及抗精神病药物,这可能导致代谢障碍.
- 代谢综合征对精神分裂症患者构成重大健康风险.
研究的目的:
- 审查代谢障碍和精神分裂症之间的关系.
- 为了强调代谢综合征在精神分裂症患者中的重要性.
- 为了检查抗精神病药物的代谢副作用.
主要方法:
- 对代谢障碍和精神分裂症研究的文献综述.
- 在这个人群中分析代谢综合征的危险因素.
- 与各种抗精神病药物相关的代谢副作用的表征.
- 在抗精神病治疗期间管理代谢综合征的治疗方法的描述.
主要成果:
- 抗精神病治疗与代谢障碍的风险增加有关.
- 特定的抗精神病药物表现出不同的代谢副作用概况.
- 代谢综合征是精神分裂症患者中普遍存在的并发症.
结论:
- 对接受抗精神病治疗的精神分裂症患者来说,对代谢障碍的有效管理至关重要.
- 了解风险因素和药物特定的副作用有助于个性化治疗策略.
- 综合护理方法是必要的,以解决精神分裂症患者的代谢健康.
相关概念视频
Psychosis and Antipsychotic Drugs: Overview
172
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
172
Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
Drug Therapy
38
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
38
Antipsychotic Drugs: Therapeutic Uses and Side Effects
119
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
119
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
442
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
442


